Comparison of the molecular and cellular phenotypes of common mouse syngeneic models with human tumors

BACKGROUND: The clinical success of immune checkpoint inhibitors demonstrates that reactivation of the human immune system delivers durable responses for some patients and represents an exciting approach for cancer treatment. An important class of preclinical in vivo models for immuno-oncology is im...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Wenyan, Myers, Jeremy S., Wang, Fang, Wang, Kai, Lucas, Justin, Rosfjord, Edward, Lucas, Judy, Hooper, Andrea T., Yang, Sharon, Lemon, Lu Anna, Guffroy, Magali, May, Chad, Bienkowska, Jadwiga R., Rejto, Paul A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941261/
https://www.ncbi.nlm.nih.gov/pubmed/31898484
http://dx.doi.org/10.1186/s12864-019-6344-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6941261/
https://www.ncbi.nlm.nih.gov/pubmed/31898484
http://dx.doi.org/10.1186/s12864-019-6344-3

Ejemplares similares